A re you suffering from symptoms of Ulcerative colitis or Crohn's disease? Is your disease still active? If so, the Baylor Scott & White Center for Inflammatory Bowel Diseases has a number of ongoing research studies that may benefit you.
BSW Center for Inflammatory Bowel Diseases conducts clinical trials of medications that hold the promise of improving the health of patients with Ulcerative Colitis or Crohn's Disease.
A Multicenter, Randomized, Double-Blind Study to Evaluate Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
A Phase 2b Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
If you would like to learn more please contact:
Themistocles Dassopoulos, M.D.Baylor Scott & White Center for Inflammatory Bowel Diseases(469) 800-7180
Christina PodiasBaylor Research InstituteDallas Clinical Trials OfficeClinical Research Coordinator 214-818-9688